Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/5/16 → 10/24/19 |
Funding
- Novartis Pharmaceuticals Corporation: $14,250.00
A Randomized, Double-blind, Double-dummy, Parallel-group Study Comparing the Efficacy and Safety of Ofatumumab versus Teriflunomide in Patients with Relapsing Multiple Sclerosis
- Coyle, Patricia K (PI)
- McLinskey, Nancy (CoPI)
- Melville, Patricia (CoPI)
Project: Research